Literature DB >> 33596681

Spanish Translation and Linguistic Validation of the Glucose Monitoring Experiences Questionnaire (GME-Q) in Continuous Glucose Monitoring Users.

Pilar I Beato-Víbora1, Lucía Lázaro-Martín1, Fabiola Gallego-Gamero1, Ana Ambrojo-López1.   

Abstract

BACKGROUND AND AIMS: The use of continuous glucose monitoring (CGM) has become standard practice in people with type 1 diabetes. The evaluation of user satisfaction is crucial. The Glucose Monitoring Experiences questionnaire (GME-Q) includes 23 items with a 5-point Likert scale to produce a total satisfaction score and three subscale scores. The study aimed to translate the GME-Q from English into Spanish and to validate its use in Spanish-speaking CGM users with type 1 diabetes.
METHODS: The linguistic translation and validation process of the GME-Q was established. T1D CGM users were asked to complete the produced Spanish version of the GME-Q and interviewed about difficulties or misunderstandings. Total satisfaction, effectiveness, convenience and intrusiveness subscales and internal consistency reliability were computed.
RESULTS: Forward and backward translations and cognitive debriefing produced a final version of the GME-Q in Spanish. Ninety-eight subjects with type 1 diabetes were selected (age: 40 ± 12 years, 63% females, Hb1c: 7.2 ± 0.9% (55 ± 10 mmol/l), pump users: 78%, CGM use: 3.7 ± 2.6 years). The completion rate was 99% and the Cronbach's alpha coefficient was 0.8. The total satisfaction score was 3.9 ± 0.4 (effectiveness: 4.1 ± 0.6, convenience: 3.8 ± 0.6, intrusiveness: 2.2 ± 0.7).
CONCLUSION: The GME-Q was translated into Spanish and validated for Spanish-speaking CGM users with type 1 diabetes.

Entities:  

Keywords:  Glucose Monitoring Experiences questionnaire; continuous glucose monitoring; type 1 diabetes; user satisfaction

Mesh:

Substances:

Year:  2021        PMID: 33596681      PMCID: PMC9264444          DOI: 10.1177/1932296821993170

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  18 in total

1.  Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial.

Authors:  Jan Bolinder; Ramiro Antuna; Petronella Geelhoed-Duijvestijn; Jens Kröger; Raimund Weitgasser
Journal:  Lancet       Date:  2016-09-12       Impact factor: 79.321

2.  Psychosocial and Human Factors During a Trial of a Hybrid Closed Loop System for Type 1 Diabetes Management.

Authors:  Rebecca N Adams; Molly L Tanenbaum; Sarah J Hanes; Jodie M Ambrosino; Trang T Ly; David M Maahs; Diana Naranjo; Natalie Walders-Abramson; Stuart A Weinzimer; Bruce A Buckingham; Korey K Hood
Journal:  Diabetes Technol Ther       Date:  2018-09-21       Impact factor: 6.118

3.  The Development and Psychometric Validation of the Diabetes Impact and Device Satisfaction Scale for Individuals with Type 1 Diabetes.

Authors:  Michelle L Manning; Harsimran Singh; Keaton Stoner; Steph Habif
Journal:  J Diabetes Sci Technol       Date:  2020-02-06

4.  Prospective Analysis of the Impact of Commercialized Hybrid Closed-Loop System on Glycemic Control, Glycemic Variability, and Patient-Related Outcomes in Children and Adults: A Focus on Superiority Over Predictive Low-Glucose Suspend Technology.

Authors:  Pilar Isabel Beato-Víbora; Fabiola Gallego-Gamero; Lucía Lázaro-Martín; Maria Del Mar Romero-Pérez; Francisco Javier Arroyo-Díez
Journal:  Diabetes Technol Ther       Date:  2020-08-28       Impact factor: 6.118

5.  Validation of measures of satisfaction with and impact of continuous and conventional glucose monitoring.

Authors: 
Journal:  Diabetes Technol Ther       Date:  2010-09       Impact factor: 6.118

6.  Psychosocial aspects of closed- and open-loop insulin delivery: closing the loop in adults with Type 1 diabetes in the home setting.

Authors:  K D Barnard; T Wysocki; H Thabit; M L Evans; S Amiel; S Heller; A Young; R Hovorka
Journal:  Diabet Med       Date:  2015-02-20       Impact factor: 4.359

7.  Flash glucose monitoring: Impact on markers of glycaemic control and patient-reported outcomes in individuals with type 1 diabetes mellitus in the real-world setting.

Authors:  M Nana; S L Moore; E Ang; Z X Lee; L N R Bondugulapati
Journal:  Diabetes Res Clin Pract       Date:  2019-10-24       Impact factor: 5.602

8.  Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes.

Authors:  Satish K Garg; Stuart A Weinzimer; William V Tamborlane; Bruce A Buckingham; Bruce W Bode; Timothy S Bailey; Ronald L Brazg; Jacob Ilany; Robert H Slover; Stacey M Anderson; Richard M Bergenstal; Benyamin Grosman; Anirban Roy; Toni L Cordero; John Shin; Scott W Lee; Francine R Kaufman
Journal:  Diabetes Technol Ther       Date:  2017-01-30       Impact factor: 6.118

9.  Flash glucose monitoring reduces glycemic variability and hypoglycemia: real-world data from Spain.

Authors:  Fernando Gomez-Peralta; Timothy Dunn; Katherine Landuyt; Yongjin Xu; Juan Francisco Merino-Torres
Journal:  BMJ Open Diabetes Res Care       Date:  2020-03

10.  Real-World Patient Reported Outcomes and Glycemic Results with Initiation of Control-IQ Technology.

Authors:  Jordan E Pinsker; Lars Müller; Alexandra Constantin; Scott Leas; Michelle Manning; Molly McElwee Malloy; Harsimran Singh; Steph Habif
Journal:  Diabetes Technol Ther       Date:  2020-08-26       Impact factor: 6.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.